Evidence map›Paper›PMID 41647953›Full record

ArticleiGIE : innovation, investigation and insights2023

Novel artificial intelligence-enabled deep learning system to enhance adenoma detection: a prospective randomized controlled study.

Jesse Lachter, Simon Christopher Schlachter, Robert Scooter Plowman, Roman Goldenberg, Yaffa Raz, Nadav Rabani, Natalie Aizenberg, Alain Suissa, Ehud Rivlin

Abstract read
In one paragraph

Article in iGIE : innovation, investigation and insights, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jesse LachterElisha Hospital, Haifa, Israel.
Simon Christopher SchlachterVerily Life Sciences, San Francisco, California, USA.
Robert Scooter PlowmanVerily Life Sciences, San Francisco, California, USA.
Roman GoldenbergVerily Life Sciences, San Francisco, California, USA.
Yaffa RazElisha Hospital, Haifa, Israel.
Nadav RabaniTechnion Institute of Technology, Haifa, Israel.
Natalie AizenbergVerily Life Sciences, San Francisco, California, USA.
Alain SuissaElisha Hospital, Haifa, Israel.
Ehud RivlinVerily Life Sciences, San Francisco, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Several artificial intelligence (AI) systems for polyp detection during colonoscopy have emerged in the gastroenterology literature and continue to demonstrate significant improvements in quality outcomes. This study assesses clinical quality outcomes during white-light colonoscopy with and without a novel AI computer-aided detection system, DEtection of Elusive Polyps (DEEP Methods: An unblinded, randomized (1:1), controlled, prospective study was performed at a single ambulatory care endoscopy center under institutional review board approval. Included participants ages 40 to 85 years were scheduled to undergo colonoscopy for screening, surveillance, or symptoms. Exclusion criteria were inflammatory bowel disease, prior colorectal surgery, known polyp referral, pregnancy, inadequate bowel prep, and incomplete colonoscopies. DEEP Results: Mean patient age was 62.4 years (SD, 10.29), and 49% were men. Of 674 colonoscopies analyzed, significant differences were found in the adenoma detection rate (ADR) between the 2 arms of the study, those performed without versus with DEEP Conclusions: Seven enrolled physicians and 5 participating nurses reported a unanimous desire to continue using DEEP

Identifiers

PMID41647953
PMCPMC12850877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.